These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 15460216

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Strong crossreaction of human anti-aprotinin antibodies from heart transplant patient with [Arg15]aprotinin.
    Brinkmann T, Körfer R, Wenzel HR, Tschesche H, Kleesiek K.
    Immunopharmacology; 1997 Jan; 35(3):221-8. PubMed ID: 9043935
    [Abstract] [Full Text] [Related]

  • 9. The kallikrein-kinin system as mediator in vasogenic brain edema. Part 3: Inhibition of the kallikrein-kinin system in traumatic brain swelling.
    Unterberg A, Dautermann C, Baethmann A, Müller-Esterl W.
    J Neurosurg; 1986 Feb; 64(2):269-76. PubMed ID: 2418176
    [Abstract] [Full Text] [Related]

  • 10. Design of an aprotinin variant with inhibitory activity against chymotrypsin and cathepsin G by recombinant DNA technology.
    Brinkmann T, Tschesche H.
    Biol Chem Hoppe Seyler; 1990 May; 371 Suppl():43-52. PubMed ID: 1698068
    [Abstract] [Full Text] [Related]

  • 11. Expression, purification and characterization of aprotinin and a human analogue of aprotinin.
    Sun Z, Lu W, Jiang A, Chen J, Tang F, Liu JN.
    Protein Expr Purif; 2009 Jun; 65(2):238-43. PubMed ID: 19152836
    [Abstract] [Full Text] [Related]

  • 12. Aprotinin and aprotinin analogues expressed in yeast.
    Norris K, Norris F, Bjørn SE, Diers I, Peterson LC.
    Biol Chem Hoppe Seyler; 1990 May; 371 Suppl():37-42. PubMed ID: 1698067
    [Abstract] [Full Text] [Related]

  • 13. Isolation and characterization of human tissue kallikrein produced in Escherichia coli: biochemical comparison to the enzymatically inactive prokallikrein and methionyl kallikrein.
    Lu HS, Hsu YR, Lu LI, Ruff D, Lyons D, Lin FK.
    Protein Expr Purif; 1996 Sep; 8(2):215-26. PubMed ID: 8812865
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Purification and characterization of an acid protease and vasopeptide kinins from Murphy-Sturm lymphosarcoma.
    Bedi GS, Balwierczak J, Back N.
    Adv Exp Med Biol; 1983 Sep; 156 (Pt B)():705-26. PubMed ID: 6344582
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A rationale for the therapeutic action of aprotinin.
    Haberland G, McConn R.
    Fed Proc; 1979 Dec; 38(13):2760-7. PubMed ID: 159836
    [Abstract] [Full Text] [Related]

  • 19. Cloning and characterization of a transmembrane-type serine protease from rat kidney, a new sodium channel activator.
    Okumura Y, Nishikawa M, Cui P, Shiota M, Nakamura Y, Adachi M, Kitamura K, Tomita K, Kido H.
    Biol Chem; 2003 Dec; 384(10-11):1483-95. PubMed ID: 14669991
    [Abstract] [Full Text] [Related]

  • 20. Purification and chemical studies on rat urinary kallikrein.
    Porcelli G, Marini-Bettòlo GB, Croxatto HR, Di Iorio M.
    Ital J Biochem; 1975 Dec; 24(3-4):175-87. PubMed ID: 1213873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.